EN

GLP‑1 medicines and prices in the US

Every GLP‑1 medicine sold in the US, at every dose: the price of a pack, and what that comes to a month and a year.

Two kinds of official price, side by side. The self-pay price is what the maker charges when you buy directly from Novo Nordisk or Lilly without insurance.1,2 The list price (wholesale acquisition cost) is the starting price before insurer rebates.3,4 Where a maker also runs a time-limited or conditional offer, we show the regular price. We never use coupons, savings cards or telehealth prices. With insurance or Medicare you pay your plan's copay instead.

Before you go further. These medicines need a prescription from a prescriber licensed in your state.5 Compounded versions are not FDA-approved.6 They have real risks: read Side effects and risks first. A lower price doesn't make a medicine right for you.

How much do Wegovy, Ozempic and Zepbound cost in the US?

Every GLP‑1 medicine sold in the US, by dose. Prices checked Oct 12, 2026.
Dose and packPer packPer monthPer year
DulaglutideAbout dulaglutide →
TrulicityType 2 diabetes onlyEli Lilly · Weekly injection, 4 single-dose pens a monthApproved for: Type 2 diabetes (adults and children 10+); Heart-risk reduction in type 2 diabetes7
0.75 mgSelf-pay4 weekly doses, a 28-day fill$3898$421$5,057
0.75 mgList price4 weekly doses, a 28-day fill$987.199$1,069$12,833
1.5 mgSelf-pay4 weekly doses, a 28-day fill$3898$421$5,057
1.5 mgList price4 weekly doses, a 28-day fill$987.199$1,069$12,833
3 mgSelf-pay4 weekly doses, a 28-day fill$3898$421$5,057
3 mgList price4 weekly doses, a 28-day fill$987.199$1,069$12,833
4.5 mgSelf-pay4 weekly doses, a 28-day fill$3898$421$5,057
4.5 mgList price4 weekly doses, a 28-day fill$987.199$1,069$12,833

Lilly's list price (wholesale acquisition cost) as TrumpRx.gov shows it, $987.19 for 4 pens at every dose.9

LiraglutideAbout liraglutide →
Liraglutide (generic Saxenda)Teva · Daily injection, 5 pens a month at 3 mgApproved for: Weight management (adults and children 12+)10
0.6 mgList price30-day supply of pens, priced by the mg$23311$233$2,796
1.2 mgList price30-day supply of pens, priced by the mg$46611$466$5,592
1.8 mgList price30-day supply of pens, priced by the mg$69911$699$8,388
2.4 mgList price30-day supply of pens, priced by the mg$93211$932$11,184
3 mgList price30-day supply of pens, priced by the mg$1,16511$1,165$13,980

No maker self-pay price published.

Teva hasn't published its price. A Teva spokesperson told Fierce Pharma the list price (wholesale acquisition cost) is $1,165 for a month at 3 mg (news report, August 2025). Lower doses use less of a pen, so we price them by the milligram.11

Liraglutide (generic Victoza)Type 2 diabetes onlyHikma; Teva · Daily injection, 18 mg pensApproved for: Type 2 diabetes (adults and children 10+)12
0.6 mg30-day supply of pens, priced by the mgNot published
1.2 mg30-day supply of pens, priced by the mgNot published
1.8 mg30-day supply of pens, priced by the mgNot published

No maker self-pay price published.

We found no list price published by Hikma or Teva for their generic Victoza.11,13

SaxendaNovo Nordisk · Daily injection, 5 pens a month at 3 mgApproved for: Weight management (adults and children 12+)10
0.6 mgList price30-day supply of pens, priced by the mg$269.8014$270$3,238
1.2 mgList price30-day supply of pens, priced by the mg$539.6114$540$6,475
1.8 mgList price30-day supply of pens, priced by the mg$809.4114$809$9,713
2.4 mgList price30-day supply of pens, priced by the mg$1,079.2214$1,079$12,951
3 mgList price30-day supply of pens, priced by the mg$1,349.0214$1,349$16,188

Being discontinued: Novo Nordisk plans its last shipments to wholesalers in late January 2027.15

No maker self-pay price published.

Novo Nordisk's list price is $1,349.02 for 5 pens of 18 mg, a month at 3 mg a day. Lower doses use less of a pen, so we price them by the milligram: 0.6 mg a day is a fifth of that.14

VictozaType 2 diabetes onlyNovo Nordisk · Daily injection, 18 mg pensApproved for: Type 2 diabetes (adults and children 10+); Heart-risk reduction in type 2 diabetes12
0.6 mgList price30-day supply of pens, priced by the mg$271.7616$272$3,261
1.2 mgList price30-day supply of pens, priced by the mg$543.5116$544$6,522
1.8 mgList price30-day supply of pens, priced by the mg$815.2716$815$9,783

No maker self-pay price published.

Novo Nordisk's list price is $543.51 for 2 pens and $815.27 for 3 pens, 18 mg each. A month (30 days) is 1 pen at 0.6 mg, 2 at 1.2 mg and 3 at 1.8 mg; for 0.6 mg we use half the 2-pen pack.16

Orforglipron
FoundayoEli Lilly · Daily tablet, 30 a monthApproved for: Weight management (adults)17
0.8 mgSelf-pay30 tablets, a 30-day fill$14918$149$1,788
0.8 mgList price30 tablets, a 30-day fill$64919$649$7,788
2.5 mgSelf-pay30 tablets, a 30-day fill$19918$199$2,388
2.5 mgList price30 tablets, a 30-day fill$64919$649$7,788
5.5 mgSelf-pay30 tablets, a 30-day fill$29918$299$3,588
5.5 mgList price30 tablets, a 30-day fill$64919$649$7,788
9 mgSelf-pay30 tablets, a 30-day fill$29918$299$3,588
9 mgList price30 tablets, a 30-day fill$64919$649$7,788
14.5 mgSelf-pay30 tablets, a 30-day fill$34918$349$4,188
14.5 mgList price30 tablets, a 30-day fill$64919$649$7,788
17.2 mgSelf-pay30 tablets, a 30-day fill$34918$349$4,188
17.2 mgList price30 tablets, a 30-day fill$64919$649$7,788

Lilly's list price (wholesale acquisition cost) is $649 for 30 tablets at every dose.19

SemaglutideAbout semaglutide →
Ozempic penType 2 diabetes onlyNovo Nordisk · Weekly injection, 1 pen (4 doses) a monthApproved for: Type 2 diabetes (adults); Heart and kidney risk reduction in type 2 diabetes20
0.25 mgSelf-pay4 weekly doses, a 28-day fill$34921$378$4,537
0.25 mgList price4 weekly doses, a 28-day fill$1,027.5122,23$675 from Jan 1, 2027$1,113$13,358
0.5 mgSelf-pay4 weekly doses, a 28-day fill$34921$378$4,537
0.5 mgList price4 weekly doses, a 28-day fill$1,027.5122,23$675 from Jan 1, 2027$1,113$13,358
1 mgSelf-pay4 weekly doses, a 28-day fill$34921$378$4,537
1 mgList price4 weekly doses, a 28-day fill$1,027.5122,23$675 from Jan 1, 2027$1,113$13,358
2 mgSelf-pay4 weekly doses, a 28-day fill$49921$541$6,487
2 mgList price4 weekly doses, a 28-day fill$1,027.5122,23$675 from Jan 1, 2027$1,113$13,358

Novo Nordisk's list price is $1,027.51 a pen at every dose. It falls to $675 a month from January 1, 2027.22,23

Ozempic pillType 2 diabetes onlyNovo Nordisk · Daily tablet, 30 a monthApproved for: Type 2 diabetes (adults); Heart-risk reduction in type 2 diabetes24
1.5 mgSelf-pay30 tablets, a 30-day fill$14921$149$1,788
1.5 mgList price30 tablets, a 30-day fill$1,027.5122$1,028$12,330
4 mgSelf-pay30 tablets, a 30-day fill$19921$199$2,388
4 mgList price30 tablets, a 30-day fill$1,027.5122$1,028$12,330
9 mgSelf-pay30 tablets, a 30-day fill$29921$299$3,588
9 mgList price30 tablets, a 30-day fill$1,027.5122$1,028$12,330

Novo Nordisk's list price is $1,027.51 for 30 tablets at every dose. Its 2027 list-price cut names Ozempic injection and Rybelsus and came before Ozempic tablets, so we keep $1,027.51.22,23

RybelsusType 2 diabetes onlyNovo Nordisk · Daily tablet, 30 a monthApproved for: Type 2 diabetes (adults); Heart-risk reduction in type 2 diabetes24
3 mgList price30 tablets, a 30-day fill$1,027.5123,25$675 from Jan 1, 2027$1,028$12,330
7 mgList price30 tablets, a 30-day fill$1,027.5123,25$675 from Jan 1, 2027$1,028$12,330
14 mgList price30 tablets, a 30-day fill$1,027.5123,25$675 from Jan 1, 2027$1,028$12,330

Being discontinued: Novo Nordisk stopped shipping it to wholesalers in May 2026 and is moving patients to Ozempic tablets.26

No maker self-pay price published.

Novo Nordisk's list price is $1,027.51 for 30 tablets at every dose. It falls to $675 a month from January 1, 2027.23,25

Wegovy penNovo Nordisk · Weekly injection, 4 pens a monthApproved for: Weight management (adults and children 12+); Heart-risk reduction; MASH liver disease27
0.25 mgSelf-pay4 weekly doses, a 28-day fill$3491$378$4,537
0.25 mgList price4 weekly doses, a 28-day fill$1,349.023,23$675 from Jan 1, 2027$1,461$17,537
0.5 mgSelf-pay4 weekly doses, a 28-day fill$3491$378$4,537
0.5 mgList price4 weekly doses, a 28-day fill$1,349.023,23$675 from Jan 1, 2027$1,461$17,537
1 mgSelf-pay4 weekly doses, a 28-day fill$3491$378$4,537
1 mgList price4 weekly doses, a 28-day fill$1,349.023,23$675 from Jan 1, 2027$1,461$17,537
1.7 mgSelf-pay4 weekly doses, a 28-day fill$3491$378$4,537
1.7 mgList price4 weekly doses, a 28-day fill$1,349.023,23$675 from Jan 1, 2027$1,461$17,537
2.4 mgSelf-pay4 weekly doses, a 28-day fill$3491$378$4,537
2.4 mgList price4 weekly doses, a 28-day fill$1,349.023,23$675 from Jan 1, 2027$1,461$17,537
7.2 mgSelf-pay4 weekly doses, a 28-day fill$3991$432$5,187
7.2 mgList price4 weekly doses, a 28-day fill$1,349.023$1,461$17,537

Novo Nordisk's list price is $1,349.02 for 4 pens at every dose, Wegovy HD 7.2 mg included. It falls to $675 a month from January 1, 2027 for every dose up to 2.4 mg. That announcement came before Wegovy HD, so we keep $1,349.02 for 7.2 mg.3,23

Wegovy pillNovo Nordisk · Daily tablet, 30 a monthApproved for: Weight management (adults); Heart-risk reduction27
1.5 mgSelf-pay30 tablets, a 30-day fill$1491$149$1,788
1.5 mgList price30 tablets, a 30-day fill$1,349.023,23$675 from Jan 1, 2027$1,349$16,188
4 mgSelf-pay30 tablets, a 30-day fill$1991$199$2,388
4 mgList price30 tablets, a 30-day fill$1,349.023,23$675 from Jan 1, 2027$1,349$16,188
9 mgSelf-pay30 tablets, a 30-day fill$2991$299$3,588
9 mgList price30 tablets, a 30-day fill$1,349.023,23$675 from Jan 1, 2027$1,349$16,188
25 mgSelf-pay30 tablets, a 30-day fill$2991$299$3,588
25 mgList price30 tablets, a 30-day fill$1,349.023,23$675 from Jan 1, 2027$1,349$16,188

Novo Nordisk's list price is $1,349.02 for 30 tablets at every dose. It falls to $675 a month from January 1, 2027.3,23

TirzepatideAbout tirzepatide →
MounjaroType 2 diabetes onlyEli Lilly · Weekly injection, 4 single-dose pens a monthApproved for: Type 2 diabetes (adults and children 10+); Heart-risk reduction in type 2 diabetes28
2.5 mgSelf-pay4 weekly doses, a 28-day fill$49929$541$6,487
2.5 mgList price4 weekly doses, a 28-day fill$1,112.1630$1,205$14,458
5 mgSelf-pay4 weekly doses, a 28-day fill$49929$541$6,487
5 mgList price4 weekly doses, a 28-day fill$1,112.1630$1,205$14,458
7.5 mgSelf-pay4 weekly doses, a 28-day fill$49929$541$6,487
7.5 mgList price4 weekly doses, a 28-day fill$1,112.1630$1,205$14,458
10 mgSelf-pay4 weekly doses, a 28-day fill$49929$541$6,487
10 mgList price4 weekly doses, a 28-day fill$1,112.1630$1,205$14,458
12.5 mgSelf-pay4 weekly doses, a 28-day fill$49929$541$6,487
12.5 mgList price4 weekly doses, a 28-day fill$1,112.1630$1,205$14,458
15 mgSelf-pay4 weekly doses, a 28-day fill$49929$541$6,487
15 mgList price4 weekly doses, a 28-day fill$1,112.1630$1,205$14,458

List price (wholesale acquisition cost) as TrumpRx.gov shows it, $1,112.16 for 4 pens at every dose.30

Zepbound KwikPenEli Lilly · Weekly injection, 1 KwikPen (4 doses) a monthApproved for: Weight management (adults); Sleep apnea with obesity (adults)31
2.5 mgSelf-pay4 weekly doses, a 28-day fill$2992$324$3,887
2.5 mgList price4 weekly doses, a 28-day fill$49932$541$6,487
5 mgSelf-pay4 weekly doses, a 28-day fill$3992$432$5,187
5 mgList price4 weekly doses, a 28-day fill$49932$541$6,487
7.5 mgSelf-pay4 weekly doses, a 28-day fill$4992$541$6,487
7.5 mgList price4 weekly doses, a 28-day fill$49932$541$6,487
10 mgSelf-pay4 weekly doses, a 28-day fill$6992$757$9,087
10 mgList price4 weekly doses, a 28-day fill$69932$757$9,087
12.5 mgSelf-pay4 weekly doses, a 28-day fill$6992$757$9,087
12.5 mgList price4 weekly doses, a 28-day fill$69932$757$9,087
15 mgSelf-pay4 weekly doses, a 28-day fill$6992$757$9,087
15 mgList price4 weekly doses, a 28-day fill$69932$757$9,087

List price (wholesale acquisition cost) as TrumpRx.gov shows it for the KwikPen: $499 a month for 2.5 to 7.5 mg and $699 for 10 to 15 mg.32

Zepbound single-dose penEli Lilly · Weekly injection, 4 single-dose pens a monthApproved for: Weight management (adults); Sleep apnea with obesity (adults)31
2.5 mg4 weekly doses, a 28-day fillNot published
5 mg4 weekly doses, a 28-day fillNot published
7.5 mg4 weekly doses, a 28-day fillNot published
10 mg4 weekly doses, a 28-day fillNot published
12.5 mg4 weekly doses, a 28-day fillNot published
15 mg4 weekly doses, a 28-day fillNot published

No maker self-pay price published: Lilly sells the single-dose pen through insurance only. Paying yourself, Lilly offers the KwikPen or vials instead.33

We found no current official list price for the single-dose pen.

Zepbound vialEli Lilly · Weekly injection, 4 single-dose vials a monthApproved for: Weight management (adults); Sleep apnea with obesity (adults)31
2.5 mgSelf-pay4 weekly doses, a 28-day fill$2992$324$3,887
2.5 mgList price4 weekly doses, a 28-day fill$1,08734$1,178$14,131
5 mgSelf-pay4 weekly doses, a 28-day fill$3992$432$5,187
5 mgList price4 weekly doses, a 28-day fill$1,08734$1,178$14,131
7.5 mgSelf-pay4 weekly doses, a 28-day fill$4992$541$6,487
7.5 mgList price4 weekly doses, a 28-day fill$1,08734$1,178$14,131
10 mgSelf-pay4 weekly doses, a 28-day fill$6992$757$9,087
10 mgList price4 weekly doses, a 28-day fill$1,08734$1,178$14,131
12.5 mgSelf-pay4 weekly doses, a 28-day fill$6992$757$9,087
12.5 mgList price4 weekly doses, a 28-day fill$1,08734$1,178$14,131
15 mgSelf-pay4 weekly doses, a 28-day fill$6992$757$9,087
15 mgList price4 weekly doses, a 28-day fill$1,08734$1,178$14,131

List price (wholesale acquisition cost) as TrumpRx.gov shows it for vials, $1,087 a month at every dose.34

Per month and per year, as in our cost calculator. Weekly medicines come as a fill of 4 doses every 28 days, so a year is 52 doses or 13 fills, and a month is a twelfth of that: a little more than one fill. Daily tablets and pens come as a 30-day supply, so a month is one fill and a year is 12 fills. List prices are shown at today's figure; where Novo Nordisk has announced a cut from January 1, 2027, the row says so.23 Rounded to the nearest dollar.

Grouped by medicine, in alphabetical order. Not sorted by price, and not a recommendation. We don't list or link pharmacies, clinics or online sellers. Your prescriber sets the medicine and the dose.

How we get these prices

Makers' regular self-pay prices and list prices (wholesale acquisition cost, from the maker or TrumpRx.gov) only. Never a coupon, savings card, conditional, telehealth or seller price. A dose with no official price is null and shown as 'Not published'. One exception, labelled: Teva's generic Saxenda list price comes from a named news report because Teva hasn't published it.

Prices checked
Oct 12, 2026
Next check
November 2026

How we write and check prices · Cost calculator

More on prices and paying

The medicines themselves What it is, how it works, results and side effects (any country).

Use this table

Download this table (CSV)

115 rows, one per dose and price type. UTF‑8, opens in Excel. Free to reuse under CC BY 4.0: cite GLP Guidebook with the page URL. Open data: all countries

How to cite

GLP Guidebook. GLP-1 medicines and prices in the US. https://glpguidebook.com/us/medicines/ (prices checked Oct 12, 2026). Licence: CC BY 4.0.

Questions people ask

How much is Wegovy without insurance?

Novo Nordisk's regular self-pay price for the Wegovy pen is $349 at every dose for a fill of 4 weekly doses: about $4,537 a year (13 fills).1 Wegovy HD (7.2 mg) is $399.1 The Wegovy pill is $149 at 1.5 mg, $199 at 4 mg and $299 at 9 and 25 mg for 30 tablets.1 The list price, before insurer rebates, is $1,349.02 for 4 pens.3

How much is Zepbound without insurance?

Lilly's regular self-pay price for the Zepbound KwikPen is $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg for a fill of 4 weekly doses: about $3,887–$9,087 a year (13 fills).2 The vial has the same regular prices.2 The single-dose pen has no self-pay price: Lilly sells it through insurance only.33

What will I pay with insurance or Medicare?

With insurance, your plan's copay, if your plan covers the medicine; for weight loss that usually needs prior authorization first.35 On Medicare, the GLP‑1 Bridge charges $50 a fill for Foundayo, Wegovy pen, Wegovy pill or Zepbound KwikPen, from Jul 1, 2026 to Dec 31, 2027, if you meet its criteria.36 See our insurance pages for the routes.

Which of these medicines are for type 2 diabetes only?

Trulicity, Liraglutide (generic Victoza), Victoza, Ozempic pen, Ozempic pill, Rybelsus and Mounjaro are approved in the US for type 2 diabetes only, and the table labels them "Type 2 diabetes only".7,12,20,24,28 Some contain the same medicine as a brand approved for weight (Ozempic and Wegovy are both semaglutide), but the approved uses, doses and price differ.

Why is a year 13 fills and not 12?

Weekly medicines come as a fill of 4 doses, which lasts 28 days. A year is 52 weeks, so it takes 13 fills, and a month (a twelfth of the year) costs a little more than one fill. Daily tablets and pens come as a 30-day supply: 12 fills a year. This is how our cost calculator counts.

Why don't you show the cheapest price or pharmacy prices?

We show the makers' regular self-pay prices and list prices only. Sellers' prices change often and differ from shop to shop, and listing them would turn a guide into a shopping list. That's why the table is grouped by medicine, never sorted by price, and names no pharmacy, clinic or online seller. How we show prices.

Sources

  1. Novo Nordisk. NovoCare: Wegovy self-pay offer and price guide (pill $149 for 1.5 mg, $199 for 4 mg, $299 for 9 and 25 mg; pen $349 a month at every dose from 0.25 to 2.4 mg, with new patients paying $199 for the first 2 months through December 31, 2026; Wegovy HD 7.2 mg $399; a month is 1 box of 4 pens or 1 bottle of 30 tablets). Checked Oct 12, 2026. Link
  2. Eli Lilly. Zepbound coverage and savings, terms of the Zepbound Self Pay Journey Program: "Regular price for a 1-month supply of Zepbound single-dose vial or KwikPen is $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, $699 for 10 mg, $699 for 12.5 mg, and $699 for 15 mg"; $449 for 7.5 to 15 mg only if each refill is within 45 days. Checked Oct 12, 2026. Link
  3. Novo Nordisk Pricing: Wegovy wholesale acquisition cost (list price) $1,349.02 for 4 pens at every dose including Wegovy HD 7.2 mg, and $1,349.02 for 30 tablets at every strength. Checked Oct 12, 2026. Link
  4. TrumpRx.gov, a US government price-listing site that does not sell medicines (Wegovy pill "$149/mo", Wegovy pen "$199/mo", Ozempic "$199/mo", Zepbound "$299/mo": starting or introductory prices). Checked Oct 12, 2026. Link
  5. American Medical Association. How state licensing has evolved to meet telehealth's challenges (physicians "licensed in the state where their patients are receiving their care"). October 12, 2023. Link
  6. FDA. FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s ("Compounded drugs are not FDA-approved… also not the same as generic drugs"). March 3, 2026. Link
  7. Eli Lilly. Trulicity (dulaglutide) US prescribing information, revised March 2026: section 1 (type 2 diabetes in adults and children 10 and older; heart-risk reduction) and section 2 (0.75 mg; 1.5 mg after 4 weeks; up 1.5 mg after at least 4 weeks; at most 4.5 mg; single-dose pens). Link
  8. Eli Lilly. LillyDirect: Trulicity (self-pay price $389 a month at every dose from 0.75 to 4.5 mg). Checked Oct 12, 2026. Link
  9. TrumpRx.gov: Trulicity single-dose pen, original price (wholesale acquisition cost) $987.19 and price $389 at every strength. Checked Oct 12, 2026. Link
  10. Novo Nordisk. Saxenda (liraglutide) US prescribing information, revised February 2026: section 1 (weight management in adults and children 12 and older), section 2 (0.6 mg a day for 1 week, then up weekly to 3 mg) and section 16 (3 mL pens of 18 mg, packs of 3 or 5). Generic liraglutide for weight management follows this label. Link
  11. News report, not an official price list: Fierce Pharma (Kevin Dunleavy), "With Saxenda generic, Teva launches first copycat GLP-1 for obesity", August 28, 2025: "Teva has established a $1,165 wholesale acquisition cost (WAC) for a monthly dose of its Saxenda generic, a company spokesperson said." Also notes Teva's June 2024 launch of a generic Victoza. Link
  12. Novo Nordisk. Victoza (liraglutide) US prescribing information, revised October 2025: section 1 (type 2 diabetes in adults and children 10 and older; heart-risk reduction), section 2 (0.6 mg a day for 1 week, then 1.2 mg; 1.8 mg after at least 1 week if needed) and section 16 (18 mg pens, packs of 2 or 3). Generic liraglutide for type 2 diabetes follows this label. Link
  13. Hikma. Hikma receives FDA approval and launches the generic version of Victoza (liraglutide) in the US: 18 mg/3 mL pens in packs of 2 or 3, for type 2 diabetes; no price given, December 2024. Link
  14. Novo Nordisk Pricing: Saxenda wholesale acquisition cost (list price) $1,349.02 for 5 pens of 3 mL (18 mg each). Checked Oct 12, 2026. Link
  15. Novo Nordisk. NovoCare: Saxenda discontinuation notice (last shipments to wholesalers in late January 2027; not due to safety or quality concerns). Oct 12, 2026. Link
  16. Novo Nordisk Pricing: Victoza wholesale acquisition cost (list price) $543.51 for 2 pens (0.6 and 1.2 mg doses) and $815.27 for 3 pens (1.8 mg dose), 18 mg each. Checked Oct 12, 2026. Link
  17. Eli Lilly. Foundayo (orforglipron) US prescribing information, revised July 2026: section 2 (0.8 mg, then 2.5 mg and 5.5 mg after at least 30 days each; up to 9, 14.5 or 17.2 mg; with or without food). Link
  18. Eli Lilly. Foundayo coverage and savings (regular self-pay prices $149 for 0.8 mg, $199 for 2.5 mg, $299 for 5.5 and 9 mg, $349 for 14.5 and 17.2 mg; temporary reductions through December 31, 2026; $299 for 14.5 and 17.2 mg with refills within 45 days). Checked Oct 12, 2026. Link
  19. Lilly USA. Information for Colorado prescribers: Foundayo (orforglipron) wholesale acquisition cost $649.00 for 30 tablets at every strength from 0.8 to 17.2 mg, CMAT-02829, April 2026. Checked Oct 12, 2026. Link
  20. Novo Nordisk. Ozempic (semaglutide) injection, US prescribing information, revised May 2026: section 1 (type 2 diabetes; heart and kidney risk reduction in type 2 diabetes), section 2 (0.25 mg for 4 weeks, then 0.5 mg; 1 mg and then 2 mg after at least 4 weeks each; maintenance 0.5, 1 or 2 mg) and section 16 (one pen of 4 weekly doses; the starter pen holds 4 doses of 0.25 mg and 2 of 0.5 mg). Link
  21. Novo Nordisk. Ozempic pill and pen price guide, US26NC00009, May 2026 (pen $349 a month for 0.25, 0.5 or 1 mg and $499 for 2 mg, with new patients paying $199 for the first 2 fills of 0.25 or 0.5 mg through December 31, 2026; pill $149 for 1.5 mg, $199 for 4 mg, $299 for 9 mg; a month is 1 pen or 1 bottle of 30 tablets). Checked Oct 12, 2026. Link
  22. Novo Nordisk Pricing: Ozempic wholesale acquisition cost (list price) $1,027.51 for 1 pen at every dose, and $1,027.51 for 30 tablets at 1.5, 4 or 9 mg. Checked Oct 12, 2026. Link
  23. Novo Nordisk. Significant reduction in US list price for Wegovy, Ozempic and Rybelsus: list price (wholesale acquisition cost) of $675 a month for Wegovy injection and tablets, Ozempic injection and Rybelsus, "effective January 1, 2027", applying "to all doses of these medicines"; no change to self-pay prices, February 24, 2026. Link
  24. Novo Nordisk. Rybelsus and Ozempic (semaglutide) tablets, US prescribing information, revised January 2026: section 1 (type 2 diabetes; heart-risk reduction in type 2 diabetes) and section 2 (Rybelsus 3 mg for 30 days, then 7 mg, then 14 mg if needed; Ozempic tablets 1.5 mg for 30 days, then 4 mg, then 9 mg if needed; not substitutable mg for mg). Link
  25. Novo Nordisk Pricing: Rybelsus wholesale acquisition cost (list price) $1,027.51 for 30 tablets at 3, 7 or 14 mg. Checked Oct 12, 2026. Link
  26. Illinois Department of Healthcare and Family Services. Provider notice May 21, 2026: Novo Nordisk "will discontinue all strengths of Rybelsus tablets"; shipments to wholesalers cease from May 2026 and inventory becomes limited from July 2026; patients move to Ozempic tablets. Link
  27. Novo Nordisk. Wegovy (semaglutide) injection and tablets, US prescribing information, revised June 2026: section 2 (pen 0.25, 0.5, 1 and 1.7 mg for 4 weeks each, then 2.4 mg; 7.2 mg after at least 4 weeks on 2.4 mg; tablets 1.5 mg for 30 days, then 4 and 9 mg for 30 days each, then 25 mg) and section 5. Link
  28. Eli Lilly. Mounjaro (tirzepatide) US prescribing information, revised August 2026: section 1 (type 2 diabetes in adults and children 10 and older; heart-risk reduction in type 2 diabetes) and section 2 (2.5 mg, then up 2.5 mg after at least 4 weeks on the current dose; at most 15 mg). Link
  29. Eli Lilly. LillyDirect: Mounjaro (single-dose pen self-pay price $499 a month at every dose from 2.5 to 15 mg). Checked Oct 12, 2026. Link
  30. TrumpRx.gov: Mounjaro single-dose pen, "Original price" (which the site says "represents the Wholesale Acquisition Cost") $1,112.16 and price $499 at every strength. Checked Oct 12, 2026. Link
  31. Eli Lilly. Zepbound (tirzepatide) US prescribing information, revised August 2026: section 2 (2.5 mg for 4 weeks, then 5 mg; up 2.5 mg after at least 4 weeks on the current dose; maintenance 5, 10 or 15 mg; at most 15 mg) and section 3 (single-dose pens and vials; KwikPen of 4 doses). Link
  32. TrumpRx.gov: Zepbound KwikPen, original price (wholesale acquisition cost) $499 for 2.5, 5 and 7.5 mg and $699 for 10, 12.5 and 15 mg. Checked Oct 12, 2026. Link
  33. Eli Lilly. LillyDirect: Zepbound (KwikPen and single-dose vial: self-pay accepted; single-dose pen: insurance only). Checked Oct 12, 2026. Link
  34. TrumpRx.gov: Zepbound vial, original price (wholesale acquisition cost) $1,087 at every strength. Checked Oct 12, 2026. Link
  35. KFF. 2025 Employer Health Benefits Survey (19% of firms with 200 or more workers cover GLP-1s primarily for weight loss; 43% of firms with 5,000 or more; usually with prior authorization). Link
  36. Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge: information for prescribers (July 1, 2026 to December 31, 2027; $50 copay outside Part D; covers Foundayo, Wegovy injection and tablets, and Zepbound KwikPen only, "The single-dose Zepbound pen and Zepbound vials are NOT covered"; not for people with type 2 diabetes, moderate-to-severe sleep apnea or MASH, who go through their Part D plan; clinical criteria; Medicare.gov/glp1bridge, 1-800-MEDICARE), Product No. 12235, June 2026. Link